Race against time: new stroke drug trial extends treatment window
NCT ID NCT06987305
Summary
This study is testing whether adding a clot-busting drug (rhTNK-tPA) before standard surgical clot removal improves recovery for stroke patients who arrive at the hospital 4.5 to 24 hours after their symptoms begin. About 820 adults with a major artery blockage will be randomly assigned to receive either the drug or a placebo before their surgery. The main goal is to see if the drug helps more people regain functional independence 90 days after their stroke.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE, ACUTE ISCHEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jiujiang First People's Hospital
RECRUITINGJiujiang, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wuhan No. 1 Hospital
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xiangtan Central Hospital
RECRUITINGXiangtan, Hunan, 421001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.